---
layout: default
title: Glossary
---

# Glossary

| Term                                             | Abbreviation | Reference                         | Definition                                                                                                                                                                                                           |
|--------------------------------------------------|--------------|-----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| **Accessory for a Medical Device**               | -            | MDR Article 2(2)                  | Article enabling specific medical device use or directly assisting its functionality.                                                                                                                                |
| **Active Device**                                | -            | MDR Article 2(4)                  | Device depending on an external energy source, acting by converting that energy. Software is also considered an active device.                                                                                       |
| **Active Implantable Device**         | -            | Directive 90/385/EEC | Any active medical device designed to be partially or totally introduced into the human body through surgical or medical intervention, or into a natural body orifice, and intended to remain in place after the procedure.                                                      |s
| **Active Therapeutic Device**     | -            | MDR Annex VIII 2.4  | An active device intended, either alone or in combination with other devices, to maintain, modify, replace, or restore biological functions or structures related to the treatment or alleviation of disease, injury, or disability. |
| **Administration by Inhalation**                 | -            |                                   | Inhalation solutions for respiratory treatment, dissolved in solvent, locally acting, some with systemic effects. Requires nebulization or vaporization.                                                             |
| **Agglomerate**                                  | -            | MDR Article 2(20)                 | Collection of weakly bound particles where the resulting surface area is close to the sum of surface areas of individual particles.                                                                                  |
| **Aggregate**                                    | -            | MDR Article 2(21)                 | Particle comprising strongly bound or fused particles.                                                                                                                                                               |
| **Authorised Representative**                    | AR           | MDR Article 2(32)                 | Natural/legal person within the EU mandated by a non-EU manufacturer to act on their behalf for regulatory obligations.                                                                                              |
| **Benefit-Risk Determination**                   | -            | MDR Article 2(24)                 | Analysis of all assessments of benefits and risks relevant for the device’s use for its intended purpose.                                                                                                            |
| **Biological Composition of Human Tissues**           | -            | -         | Human tissues are composed of: a) **Epithelial tissue** - layers of cells covering internal and external surfaces, divided into surface and glandular epithelium; b) **Connective and supporting tissue** - provides structural support and fills spaces, including bone, cartilage, fat tissue, and specialized tissues like blood; c) **Muscle tissue** - cells specialized for active movement; d) **Nervous tissue** - cells forming the brain, spinal cord, and peripheral nerves. |
| **Biological Functions**      | -            | -         | Functions related to life processes or biological activities.                                                                                                       |
| **Biological Structures**     | -            | -         | Organized relationships between parts of a system. In biology, the term also refers to systems or subsystems of organisms, such as organs, proteins, cells, or membranes. |
| **Body Orifice**                                 | -            | MDR Annex VIII 2.1                | Natural opening, external surface of the eyeball, or surgically created permanent opening (e.g., stoma).                                                                                                             |
| **Body Fluids**              | -            |        | The water present in various compartments of the human body, including dissolved substances (e.g., electrolytes). Commonly refers to perceptible fluids like urine or saliva, classified as transcellular body fluids.         |
| **Body Part**                | -            |        | A segment of the body recognized as a functional morphological unit (e.g., leg, arm).                                                                                                  |
| **CE Marking**                                   | -            | MDR Article 20                    | Marking indicating compliance with MDR and other applicable Union legislation.                                                                                                                                       |
| **CE Marking of Conformity**                     | -            | MDR Article 2(43)                 | Marking indicating that a device complies with MDR and other applicable Union legislation.                                                                                                                           |
| **Centrifugation**  | -            | -         | Separation process used in medicine to separate cells or biomolecules from suspensions (e.g., blood) through centrifugal force.                                                                        |
| **Clinical Evaluation**                          | -            | MDR Article 2(44)                 | Systematic process to collect, analyse, and assess clinical data to verify safety and performance, including benefits.                                                                                               |
| **Clinical Investigation**                       | -            | MDR Article 2(45)                 | Systematic investigation involving human subjects to assess safety and performance.                                                                                                                                  |
| **Closed-Loop System**        | -            | -         | A control system designed to maintain a controlled variable (setpoint) despite external disturbances. The system continuously compares the actual value to the setpoint and adjusts an actuator to minimize the difference. Example: A thermostat controlling heating. |
| **Compatibility**                                | -            | MDR Article 2(25)                 | Ability of a device to perform with other devices without losing performance or requiring modification.                                                                                                              |
| **Compromised Skin or Mucous Membrane**   | -            | -         | Area of skin or mucous membrane showing pathological changes, changes resulting from disease, or the presence of a wound.                                       |
| **Conformity Assessment**                        | -            | MDR Article 2(40)                 | Process demonstrating fulfillment of MDR requirements.                                                                                                                                                               |
| **Conformity Assessment Body**                   | -            | MDR Article 2(41)                 | Body performing third-party conformity assessment activities such as calibration, testing, certification, and inspection.                                                                                            |
| **Control**                    | -            | -                    | Comparison between planned and actual values, including analysis of deviation causes; does not include corrective actions. Performed by persons or organizational units directly or indirectly involved in the realization process. |
| **Control (Process Control)** | -            | -         | Guiding or influencing a process to achieve desired outcomes.                                                                                                                                                                                                                                                                                                                    |
| **Custom-Made Device**                           | -            | MDR Article 2(3)                  | Device made for a specific patient based on professional prescription, with specific design features.                                                                                                                |
| **Derivative**                                   | -            | MDR Article 2(17)                 | Non-cellular substance extracted from human/animal tissue or cells via manufacturing process, free of cells/tissues.                                                                                                 |
| **Diagnostic Function**       | -            | -         | All measures aimed at identifying a disease, including anamnesis, physical examination, diagnostic procedures, and analysis of tissues and excretions.                                                                     |
| **Diagnostic Purposes**    | -            |        | All measures aimed at identifying a disease, including anamnesis, physical examinations, further diagnostic procedures, and analysis of tissues and excretions.                                                                          |
| **Disinfection**    | -            | ISO 17664   | Process for reducing the number of viable microorganisms to a level previously deemed appropriate for a defined purpose.                                        |
| **Distributor**                                  | -            | MDR Article 2(34)                 | Natural/legal person making devices available on the market up to the point of putting into service.                                                                                                                 |
| **Direct Diagnosis**          | -            | MDR Annex VIII 3.7    | Diagnosis that directly provides the identification of the disease or health condition itself, or delivers information essential for diagnosis.                                                                                      |
| **Directive 2001/83/EC**                         | -            | Directive 2001/83/EC              | Establishes a Community code relating to medicinal products for human use.                                                                                                                                           |
| **Disease**                    | -            | -         | Disruption of vital processes in organs or the entire organism, resulting in subjectively perceived and/or objectively detectable physical, mental, or emotional changes. Distinguished from functional complaints without identifiable medical cause. |
| **Dosage Form**             | -            | -              | Physical form in which a medicinal product is presented, such as solid, liquid, semi-solid, or special forms.                                                                                   |
| **Economic Operator**                            | -            | MDR Article 2(35)                 | Manufacturer, authorised representative, importer, distributor, or Article 22(1)/(3) entity.                                                                                                                         |
| **Efficacy (of a Medicinal Product)**            | -            |                                   | Ability of a procedure/substance to causally induce a predefined change (biochemical processes, cells, tissues, organisms).                                                                                          |
| **Energy** | - | - | The capacity to perform work, release heat, or emit light (SI unit: Joule, J). Energy is governed by the law of conservation of energy, meaning it can neither be created nor destroyed but only transformed. Energy is essential for all natural processes, enabling movement, acceleration, lifting, heating, and illumination. It defines the state of a body or electromagnetic field and is characterized by conservation, transformation, and degradation. |
| **Energy Source**           | -            |                        | A means of obtaining usable energy for an application, including nuclear, fossil fuels, and renewable energy sources such as solar, wind, hydro, and geothermal energy. |
| **EUDAMED**                                      | -            | MDR Article 33                    | EU database integrating systems on devices, operators, certificates, clinical investigations, and vigilance.                                                                                                         |
| **Falsified Device**                             | -            | MDR Article 2(9)                  | Any device with false presentation of identity, source, or CE marking certificates/documents, excluding unintentional non-compliance.                                                                                |
| **Field Safety Corrective Action**               | FSCA         | MDR Article 2(68)                 | Corrective action by manufacturer to prevent or reduce serious incident risk for a marketed device.                                                                                                                  |
| **Field Safety Notice**                          | FSN          | MDR Article 2(69)                 | Communication from manufacturer to users/customers about a field safety corrective action.                                                                                                                           |
| **Filtration**      | -            | -         | Mechanical separation process using a filter to remove particles or molecules from a suspension or aerosol. Depending on the filter pore size, smaller molecules may selectively pass through the membrane. |
| **General Safety and Performance Requirements**  | GSPR         | MDR Annex I                       | Core requirements ensuring health and safety protection.                                                                                                                                                             |
| **Generic Device Group**                         | -            | MDR Article 2(7)                  | Set of devices with the same or similar intended purpose or commonality of technology, allowing them to be classified in a generic way without reflecting specific characteristics.                                  |
| **Hazard**                            | -            | MEDDEV 2.7/1 rev.4  | A potential source of harm.                                                                                                                                                                                                       |
| **Health Institution**                           | -            | MDR Article 2(36)                 | Organisation whose primary purpose is care or treatment of patients or promotion of public health.                                                                                                                   |
| **Health Status**          | -            | -         | Ideal state of complete well-being without any physical, psychological, or social disturbances.                                                                                          |
| **Human Embryos**          | -            | -                  | An embryo is a living being in the early stages of development. The process of embryo formation is called embryogenesis, and the study of embryonic development falls under embryology.                                                 |
| **Hydration**       | -            | -         | Process where a hard, water-absorbent material is brought into contact with a biocompatible moisturizing fluid, which is then absorbed by the material (e.g., a contact lens). |s
| **Implantable Device**                           | -            | MDR Article 2(5)                  | Any device, including those partially or wholly absorbed, intended to be totally or partially introduced into the human body or natural orifice by clinical intervention and intended to remain after the procedure. |
| **Implantation**                                      | -            | -         | The placement of artificial materials (implants) into the human body by a physician.                                                                                                                                                                                                                                                                                    |
| **Importer**                                     | -            | MDR Article 2(33)                 | Natural/legal person placing a third-country device on the EU market.                                                                                                                                                |
| **Immunological Mechanism**                      | -            | MDR Annex VIII 1.4                | Mode of action through stimulation/mobilisation of cells/products involved in immune response.                                                                                                                       |
| **Inhalation**                                   | -            |                                   | Inhalation of gases or aerosols.                                                                                                                                                                                     |
| **Influence**                 | -            | -         | Any action or situation that alters attitudes, decisions, or actions.                                                                                                                                                                                                                                                                                                           |
| **Information**            | -            |        | Abstract representation of a material or immaterial state, transmitted from an information carrier to a perceiving entity (entity = an object of consideration that forms its own unit). Examples: blood pressure values, digital vision exercises. |
| **Infusion**    | -            | -         | Controlled administration or introduction of larger volumes of fluid into specific body compartments, usually referring to intravenous infusion in medical practice. |
| **Instructions for Use**                         | -            | MDR Article 2(14)                 | Information provided by the manufacturer to inform users of the device’s intended purpose, proper use, and necessary precautions.                                                                                    |
| **Intended Purpose**                             | -            | MDR Article 2(12)                 | Use specified by the manufacturer on labels, instructions for use, or promotional materials, and in clinical evaluation.                                                                                             |
| **Internal Exposure**                            | -            | MDR Recital 15                    | Proportion of original dose absorbed and distributed via bloodstream.                                                                                                                                                |
| **Invasive Device**                              | -            | MDR Article 2(6)                  | Any device which, in whole or in part, penetrates inside the body, either through a body orifice or through the surface of the body.                                                                                 |
| **Intact Skin**                                  | -            |                         | Skin that is not damaged or injured.                                                                                                                                                                                 |
| **Interoperability**                             | -            | MDR Article 2(26)                 | Ability of devices (including software) to exchange and use information for correct execution of a specified function.                                                                                               |
| **In-vivo Imaging**           | -            | -         | Processes and reactions observed directly within a living organism under physiological conditions. Phases II and III of clinical trials for medicinal products are conducted in vivo.                                                                                                                                                                                                                                                                                                                             |
| **Ionising Radiation**        | -            | -         | High-energy electromagnetic waves (X-rays, gamma rays) and particles (alpha particles, beta particles, neutrons) capable of removing electrons from atoms (ionisation). Ionising radiation can damage or destroy cells, potentially causing acute illness or increased cancer risk depending on dose, affected organs, and type of cellular damage. Sources include radioactive substances (e.g., uranium, radon) and devices such as X-ray and radiotherapy equipment. |
| **Irreversible**           | -            | -         | Physical or psychological deficits that cannot be reversed by the body’s own repair mechanisms or medical intervention (Restitutio ad integrum).                                          |
| **Label**                                        | -            | MDR Article 2(13)                 | Written, printed, or graphic information appearing on the device, packaging, or grouped packaging.                                                                                                                   |
| **Lay Person**                                   | -            | MDR Article 2(38)                 | Individual without formal education in a relevant healthcare or medical discipline.                                                                                                                                  |
| **Long-Term Use**                                | -            | MDR Annex VIII Chapter 1          | Intended for continuous use for more than 30 days under normal conditions.                                                                                                                                           |
| **Making Available on the Market**               | -            | MDR Article 2(27)                 | Supply of a device, other than an investigational device, for distribution, consumption, or use on the Union market in the course of a commercial activity.                                                          |
| **Manufacturer**                                 | -            | MDR Article 2(30)                 | Person manufacturing/refurbishing a device and placing it on the market under their name or trademark.                                                                                                               |
| **Medical Device**                               | -            | MDR Article 2(1)                  | Instrument, software, implant, etc., for diagnosis, prevention, monitoring, treatment, etc., acting primarily through non-pharmacological, non-immunological, non-metabolic means.                                   |
| **Medicinal Product**                            | -            | Directive 2001/83/EC Article 1(2) | Substance or combination for treating/preventing disease, or restoring/correcting/modifying physiological functions through pharmacological, immunological, or metabolic action, or for diagnosis.                   |
| **Metabolic Mechanism**                          | -            | MDR Annex VIII 1.4                | Mode of action modifying (initiating, interrupting, altering) normal chemical processes.                                                                                                                             |
| **Metabolite**                                   | -            |                                   | Intermediate product in a biochemical metabolic process.                                                                                                                                                             |
| **Nanomaterial**                                 | -            | MDR Article 2(18)                 | Natural/incidental/manufactured material with ≥50% particles between 1-100 nm; includes fullerenes, graphene flakes, single-walled carbon nanotubes <1 nm.                                                           |
| **Non-Viable**                                   | -            | MDR Article 2(16)                 | Having no potential for metabolism or multiplication.                                                                                                                                                                |
| **Notified Body**                                | -            | MDR Article 2(42)                 | Conformity assessment body designated under MDR.                                                                                                                                                                     |
| **Parameter**               | -            |                        | A characteristic or measurable factor of an object or system, such as body parameters (e.g., height, weight, pulse, blood pressure) or laboratory/test parameters.  |
| **Particle**                                     | -            | MDR Article 2(19)                 | Minute piece of matter with defined physical boundaries.                                                                                                                                                             |
| **Performance**                                  | -            | MDR Article 2(22)                 | Ability of a device to achieve its intended purpose as stated by the manufacturer.                                                                                                                                   |
| **Person Responsible for Regulatory Compliance** | PRRC         | MDR Article 15                    | Qualified person ensuring regulatory compliance within a manufacturer.                                                                                                                                               |
| **Pharmacological Mechanism**                    | -            | MDR Annex VIII 1.4                | Mode of action involving interaction between substance molecules and cellular components (e.g., receptors), triggering/blocking responses.                                                                           |
| **Physiological Processes** | -            | -         | Normal processes and body functions of the human organism. Physiological refers to functions that are natural, healthy, or correspond to normal life processes. |
| **Physiological State**       | -            | -         | Refers to natural, healthy body functions and processes. Opposite of physiological (natural) is pathological (diseased).                                                                                                     |
| **Placing on the Market**                        | -            | MDR Article 2(28)                 | First making available of a device (not investigational) on the Union market.                                                                                                                                        |
| **Procedure Pack**                               | -            | MDR Article 2(10)                 | Combination of products packaged together for use for a specific medical purpose.                                                                                                                                    |
| **Post-Market Surveillance**                     | PMS          | MDR Article 2(60)                 | All activities by manufacturers and operators to proactively collect and review device performance and safety data to identify and apply corrective/preventive actions.                                              |
| **Potential (high/medium)**                      | -            | MDR Recital 15                    | Products with nanoparticles having high/medium internal exposure potential should undergo strictest conformity assessment procedures.                                                                                |
| **Potential Hazard**         | -            | ISO 14971      | A potential source of harm (e.g., viruses, ionizing radiation, moving parts).                                                                                                         |
| **Power Source**            | -            |                        | An active circuit element capable of supplying a constant current to a circuit, regardless of the voltage developed at its terminals.                                |
| **Putting into Service**                         | -            | MDR Article 2(29)                 | Device made available to final user as ready for use in the EU for the first time.                                                                                                                                   |
| **Radiological Diagnostics**  | -            | -         | Area of diagnostic radiology focused on detecting diseases using various non-invasive imaging techniques.                                                                                                                                                                                                                                                                       |
| **Radiological Therapy**      | -            | -         | Application of short-wavelength electromagnetic waves or particles for therapeutic or palliative purposes, primarily used to treat malignant diseases (cancer). Conducted by specialists in radiation therapy or radio-oncology.                                                                                                                             |
| **Radiopharmaceutical**       | -            | -         | A medicinal product used in nuclear medicine, either consisting solely of a radioactive substance or a carrier linked to a radioactive substance. Radiopharmaceuticals are primarily used for diagnostics (e.g., scintigraphy, PET, SPECT) where they visualize metabolic processes rather than static images, as seen in X-rays. They can also be used therapeutically to treat diseases or conditions (radiotherapeutics).                                                                 |
| **Reprocessing**                                 | -            | MDR Article 2(39)                 | Process carried out on a used device to allow safe reuse, including cleaning, disinfection, sterilisation, and testing.                                                                                              |
| **Risk**                                         | -            | MDR Article 2(23)                 | Combination of the probability of occurrence of harm and the severity of that harm.                                                                                                                                  |
| **Route of Administration**  | -            |     | Describes how a medicinal product or medical device is applied: local or systemic, external (e.g., skin, hair) or internal via the bloodstream. Common forms include oral, nasal, intravenous, subcutaneous, inhalative, etc. |
| **Serious Deterioration**                | -            | MEDDEV 2 12-1 rev. 8 | a) Life-threatening illness, b) Permanent impairment of a body function or structure, c) Condition requiring medical or surgical intervention to prevent a) or b), d) Indirect harm due to incorrect diagnosis, IVD test results, or use of ART devices per manufacturer instructions (including use errors), e) Fetal distress, fetal death, or congenital anomaly or birth defect.             |
| **Serious Incident**                             | -            | MDR Article 2(64)                 | Incident leading to death, serious deterioration of health, or serious public health threat.                                                                                                                         |
| **Significant Changes**     | -            |                        | Any modification to a product that could affect compliance with essential requirements or alter its intended use or contraindications as defined by the manufacturer. |
| **Single-Use Device**                            | -            | MDR Article 2(8)                  | Device intended for use on one individual during a single procedure.                                                                                                                                                 |
| **Substances**                                   | -            | MEDDEV 2.1/3 rev3                 | Substances achieving intended effect through physico-chemical or physical means, excluding pharmacological, immunological, or metabolic actions.                                                                     |
| **Substances_**              | -            | Directive 2001/83/EC Article 1(3) | All substances of any origin, including human (e.g., blood products), animal, plant, and chemical substances derived through extraction, processing, or synthetic means. |
| **Surgical Procedure**                   | -            | -                  | Manual or instrumental intervention cutting or suturing tissue to treat disease, injury, or deformity. Modern techniques may include laser or radiation cutting, and wound closure without sutures.                                                                                                                         |
| **Sterilisation**   | -            | ISO 17664   | Process of freeing a product from viable microorganisms.                                                                                                       |
| **System**                                       | -            | MDR Article 2(11)                 | Combination of products, either packaged together or not, intended to be interconnected or combined to achieve a specific medical purpose.                                                                           |
| **Systemic**                                     | -            |                                   | Absorption into blood/lymphatic system for distribution throughout the body.                                                                                                                                         |
| **Therapeutic Purposes**   | -            |        | The treatment or healing of a disease.                                                                                                                                                                                                  |
| **Tissue**                   | -            |        | All cellular components of the human body that are not organs, including human cells.                                                                                                   |
| **Unique Device Identifier**                     | UDI          | MDR Article 27                    | Device identification and traceability system using globally accepted standards.                                                                                                                                     |
| **User**                                         | -            | MDR Article 2(37)                 | Any healthcare professional or lay person who uses a device.                                                                                                                                                         |
| **Vigilance**                                    | -            | MDR Article 2(58)                 | Activities to collect, analyze, and respond to information on adverse events and device problems to minimize risk.                                                                                                   |
| **Visible Spectral Range**    | -            | -         | Defined wavelength range used for temperature measurement by infrared sensors. Common non-contact temperature measurements are performed at wavelengths around 1.0 µm or 1.6 µm (metals), 5.2 µm (glass), and 7.5 to 14 µm (most non-metallic objects).                         |
| **Vital Body Functions**      | -            | -                    | Body functions essential to sustain life processes. Primarily includes respiration and cardiovascular function, but also brain function (consciousness), fluid-electrolyte balance, acid-base balance, renal function, and thermoregulation. |
| **Vital Physiological Parameters**    | -            | -         | Measurable indicators of essential body functions assessed during vital signs monitoring. The four fundamental vital parameters are heart rate, respiratory rate, blood pressure, and body temperature. Oxygen saturation is also commonly monitored in intensive care settings. |
| **X-ray Radiation**                              | -            |                         | X-rays are electromagnetic waves with photon energy higher than that of ultraviolet light.                                                                                                                           |

### References
- [EU MDR Full Text](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745)
- [MDCG Guidance Documents](https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en)
- [ISO 14971 - Risk Management](https://www.iso.org/standard/72704.html)
- [ISO 13485 - Quality Management](https://www.iso.org/standard/59752.html)
